table of content
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Overall Market Size
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size: 2023 VS 2030
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Markets, 2023 & 2030
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2024
4.2.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2025-2030
4.2.3 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2023 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2024
5.2.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2025-2030
5.2.3 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2023 & 2030
6.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2024
6.2.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2025-2030
6.2.3 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.3.2 US Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.4.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.3 France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.4 U.K. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.5 Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.8 Benelux Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.6.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.6.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.7.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7.5 UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
7 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.1.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.2.4 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.4.4 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.5.4 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.6.4 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Company Summary
7.7.2 CARsgen Therapeutics Business Overview
7.7.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.7.4 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.7.5 CARsgen Therapeutics Key News & Latest Developments
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Company Summary
7.8.2 Autolus Therapeutics Business Overview
7.8.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.8.4 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.8.5 Autolus Therapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Mustang Bio
7.10.1 Mustang Bio Company Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.10.4 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.10.5 Mustang Bio Key News & Latest Developments
7.11 Bluebird Bio
7.11.1 Bluebird Bio Company Summary
7.11.2 Bluebird Bio Business Overview
7.11.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.11.4 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.11.5 Bluebird Bio Key News & Latest Developments
7.12 Cellectis
7.12.1 Cellectis Company Summary
7.12.2 Cellectis Business Overview
7.12.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.12.4 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.12.5 Cellectis Key News & Latest Developments
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Company Summary
7.13.2 Allogene Therapeutics Business Overview
7.13.3 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.13.4 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.13.5 Allogene Therapeutics Key News & Latest Developments
7.14 Celyad
7.14.1 Celyad Company Summary
7.14.2 Celyad Business Overview
7.14.3 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.14.4 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.14.5 Celyad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
